Advertisement
Screener

Orthofix Medical Inc. (OFIX) OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax

Orthofix Medical Inc. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax

Orthofix Medical Inc. (OFIX) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax of $1.67 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2025-11-04.

Financial Statements › Income Statement › Other Income

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax · last filed 2026-02-24

  • Orthofix Medical Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2024-09-30 was $0.00.
  • Orthofix Medical Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
  • Orthofix Medical Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2024-03-31 was $1.67M.
  • Orthofix Medical Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2023-12-31 was -$1.34M, a 217.31% decline year-over-year.
  • Orthofix Medical Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2023 was -$1.33M, a 437.72% decline from fiscal 2022.
  • Orthofix Medical Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2022 was $395.00K.
  • Orthofix Medical Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2021 was -$942.00K, a 150.08% decline from fiscal 2020.
  • Orthofix Medical Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2020 was $1.88M.
Period endOCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 3 monthOCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 6 monthOCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 9 monthOCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 12 month
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$0.00
derived: sum of 2 quarters · filed 2025-11-04
$1.67M
10-Q · filed 2025-11-04
$329.00K
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$1.67M
10-Q · filed 2025-08-05
$329.00K
derived: sum of 3 quarters · filed 2026-02-24
$19.00K
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$1.67M
10-Q · filed 2025-05-06
$329.00K
derived: sum of 2 quarters · filed 2026-02-24
$19.00K
derived: sum of 3 quarters · filed 2026-02-24
$400.00K
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$1.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$1.65M
derived: sum of 2 quarters · filed 2026-02-24
-$1.27M
derived: sum of 3 quarters · filed 2026-02-24
-$1.33M
10-K · filed 2026-02-24
2023-09-30-$310.00K
10-Q · filed 2024-11-07
$71.00K
derived: sum of 2 quarters · filed 2024-11-07
$8.00K
10-Q · filed 2024-11-07
$1.15M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$381.00K
10-Q · filed 2024-08-06
$318.00K
10-Q · filed 2024-08-06
$1.46M
derived: sum of 3 quarters · filed 2025-02-25
$1.23M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31-$63.00K
10-Q · filed 2024-05-07
$1.08M
derived: sum of 2 quarters · filed 2025-02-25
$845.00K
derived: sum of 3 quarters · filed 2025-02-25
$1.01M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$908.00K
derived: sum of 2 quarters · filed 2025-02-25
$1.07M
derived: sum of 3 quarters · filed 2025-02-25
$395.00K
10-K · filed 2025-02-25
2022-09-30-$236.00K
10-Q · filed 2023-11-08
-$75.00K
derived: sum of 2 quarters · filed 2023-11-08
-$749.00K
10-Q · filed 2023-11-08
-$1.58M
derived: sum of 4 quarters · filed 2024-03-05
2022-06-30$161.00K
10-Q · filed 2023-08-08
-$513.00K
10-Q · filed 2023-08-08
-$1.34M
derived: sum of 3 quarters · filed 2024-03-05
-$827.00K
derived: sum of 4 quarters · filed 2024-03-05
2022-03-31-$674.00K
10-Q · filed 2023-05-09
-$1.50M
derived: sum of 2 quarters · filed 2024-03-05
-$988.00K
derived: sum of 3 quarters · filed 2024-03-05
-$890.00K
derived: sum of 4 quarters · filed 2024-03-05
2021-12-31-$827.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05
-$314.00K
derived: sum of 2 quarters · filed 2024-03-05
-$216.00K
derived: sum of 3 quarters · filed 2024-03-05
-$942.00K
10-K · filed 2024-03-05
2021-09-30$513.00K
10-Q · filed 2022-11-03
$611.00K
derived: sum of 2 quarters · filed 2022-11-03
-$115.00K
10-Q · filed 2022-11-03
2021-06-30$98.00K
10-Q · filed 2022-08-05
-$628.00K
10-Q · filed 2022-08-05
2021-03-31-$726.00K
10-Q · filed 2022-05-06
2020-12-31$1.88M
10-K · filed 2023-03-06
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$0.00
derived: sum of 2 quarters · filed 2022-02-25
$0.00
derived: sum of 3 quarters · filed 2022-02-25
-$2.59M
10-K · filed 2022-02-25
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$0.00
derived: sum of 2 quarters · filed 2020-11-05
-$2.59M
10-Q · filed 2020-11-05
-$4.02M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$2.59M
10-Q · filed 2020-08-06
-$4.02M
derived: sum of 3 quarters · filed 2021-02-26
-$2.78M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31-$2.59M
10-Q · filed 2020-05-08
-$4.02M
derived: sum of 2 quarters · filed 2021-02-26
-$2.78M
derived: sum of 3 quarters · filed 2021-02-26
-$823.00K
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31-$1.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
-$190.00K
derived: sum of 2 quarters · filed 2021-02-26
$1.77M
derived: sum of 3 quarters · filed 2021-02-26
$1.77M
10-K · filed 2021-02-26
2018-09-30$1.24M
10-Q · filed 2019-10-28
$3.20M
derived: sum of 2 quarters · filed 2019-10-28
$3.20M
10-Q · filed 2019-10-28
2018-06-30$1.96M
10-Q · filed 2019-08-05
$1.96M
10-Q · filed 2019-08-05
2017-12-31$7.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
$7.05M
derived: sum of 2 quarters · filed 2020-02-24
$7.05M
derived: sum of 3 quarters · filed 2020-02-24
$3.83M
10-K · filed 2020-02-24
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29
$0.00
derived: sum of 2 quarters · filed 2018-10-29
-$3.22M
10-Q · filed 2018-10-29
-$5.81M
derived: sum of 4 quarters · filed 2019-02-25
2017-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
-$3.22M
10-Q · filed 2018-08-06
-$5.81M
derived: sum of 3 quarters · filed 2019-02-25
-$1.10M
derived: sum of 4 quarters · filed 2019-02-25
2017-03-31-$3.22M
10-Q · filed 2018-04-30
-$5.81M
derived: sum of 2 quarters · filed 2019-02-25
-$1.10M
derived: sum of 3 quarters · filed 2019-02-25
-$4.14M
derived: sum of 4 quarters · filed 2019-02-25
2016-12-31-$2.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25
$2.12M
derived: sum of 2 quarters · filed 2019-02-25
-$920.00K
derived: sum of 3 quarters · filed 2019-02-25
-$1.74M
10-K · filed 2019-02-25
2016-09-30$4.70M
10-Q · filed 2017-10-30
$1.67M
derived: sum of 2 quarters · filed 2017-10-30
$843.00K
10-Q · filed 2017-10-30
2016-06-30-$3.04M
10-Q · filed 2017-08-07
-$3.86M
10-Q · filed 2017-08-07
2016-03-31-$824.00K
10-Q · filed 2017-05-04
2015-12-31-$3.35M
10-K · filed 2018-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
CARLSMED, INC. (CARL)United States$0.405B
Embecta Corp. (EMBC)United States$0.319B2.10
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26